News Archive – Page 17 of 49 – Cambridge Enterprise

Jim Huntington Z Factor (AATD Treatment)

Cambridge spin-out doses first subject with treatment for alpha-1-antitrypsin deficiency

Cambridge Enterprise leads strategic funding round for Bond180

Research England Backs efforts To Boost Value realised from University Research

Research England backs efforts to boost value realised from university research

Partnering with LAU Fouad Makhzoumi Innovation Centre

Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion

Cambridge spin-out Qkine secures £1.5m Series A funding to accelerate global-scale-up

Cambridge spin-out Flusso raises $5.7m Series A to disrupt $8bn flow monitoring market

Xampla Microcaps

Xampla, breakthrough plant protein solution for ‘hidden plastics’, receives funding boost

Switching on a key cancer gene could provide first curative treatment for heart disease

Cambridge spin-out Poro Technologies raises £1.5m seed investment

Nurse using SAMBA machines

Rapid COVID-19 diagnostic test developed by Cambridge spin-out to be deployed in hospitals

Cambridge spin-out ApcinteX begins dosing haemophilia patients in second part of clinical trial

257-272 of 585

Page of 49